To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ZNF366andMRPS27TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
423 representative clones for gene ZNF366andMRPS27 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB277097 uterus .a 1 to 493 2 to 494   tiling clone, to resequence, capped   493/493
(100 %)
1 diff
(99.8 %id)
DB352234 uterus .a 3064 to 3618 555 to 1   tiling clone, to resequence,   555/555
(100 %)
0 diff
(100 %id)
DB164436 thymus .a 3220 to 3722 2 to 502   tiling clone, capped   501/501
(100 %)
1 diff
(99.9 %id)
DB347054 thymus .a 4488 to 5019 532 to 1   tiling clone,   532/532
(100 %)
0 diff
(100 %id)
AK097115 Spleen .b 1 to 2762 9 to 2770 exact tiling clone, available from FLJ,   2770/2770
(100 %)
4 diff
(99.9 %id)
NM_152625.1   .b 1 to 2762 9 to 2770 exact RefSeq,   2770/2770
(100 %)
4 diff
(99.9 %id)
DA934564 Spleen .b 1 to 585 9 to 593   capped   592/592
(100 %)
0 diff
(100 %id)
BX504602   .b 1 to 507 7 to 513       513/513
(100 %)
2 diff
(99.7 %id)
CB988504 Human Placenta, placenta .b 1 to 656 30 to 691       664/812
(81 %)
22 diff
(97.3 %id)
CB989910 Human Placenta, placenta .b 1 to 736 30 to 769       742/769
(96 %)
11 diff
(98.6 %id)
CB959873 Human Placenta, placenta .b 1 to 557 30 to 587       560/845
(66 %)
10 diff
(98.9 %id)
CB960883 Human Placenta, placenta .b 1 to 666 30 to 705       678/800
(84 %)
19 diff
(97.7 %id)
CD109920 Human Placenta, placenta .b 1 to 753 30 to 787       760/789
(96 %)
20 diff
(97.5 %id)
DA318948 hippocampus .b 1 to 632 3 to 634   capped   633/633
(100 %)
0 diff
(100 %id)
DA111328 cerebellum .b 1 to 579 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA856390 placenta .b 6 to 566 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DB093947 testis .b 12 to 560 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DB275963 uterus .b 15 to 583 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
BP198922 brain .b 19 to 603 1 to 584       584/584
(100 %)
1 diff
(99.9 %id)
BC029955 Brain, Lung, Testis, adult, pooled whole .b 19 to 1210 1 to 1192   available from MGC,   1192/1192
(100 %)
3 diff
(99.8 %id)
BI819503 pooled brain, lung, testis .b 19 to 862 1 to 836   available from MGC,   836/836
(100 %)
21 diff
(97.5 %id)
TI_57199358   .b 19 to 862 36 to 871       836/871
(95 %)
22 diff
(97.5 %id)
DA404362 thalamus .b 20 to 587 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
BI523869 pooled lung and spleen .b 20 to 820 1 to 796       796/796
(100 %)
9 diff
(98.9 %id)
TI_44158867   .b 20 to 820 69 to 864       796/864
(92 %)
15 diff
(98.3 %id)
DA864008 placenta .b 20 to 620 2 to 602   capped   601/601
(100 %)
0 diff
(100 %id)
DB239196 trachea .b 20 to 585 2 to 567   capped   566/567
(99 %)
1 diff
(99.9 %id)
TI_57179756   .b 36 to 803 66 to 833       768/833
(92 %)
17 diff
(98.0 %id)
BI770486 pooled lung and spleen .b 37 to 803 1 to 767       767/767
(100 %)
11 diff
(98.6 %id)
DB290935 uterus .b 40 to 612 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA109190 cerebellum .b 41 to 619 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA852861 placenta .b 41 to 597 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DB232097 trachea .b 45 to 639 2 to 596   capped   595/595
(100 %)
0 diff
(100 %id)
DA588600 lung .b 47 to 630 2 to 585   capped   584/584
(100 %)
1 diff
(99.9 %id)
DR002663 fetal brain .b 50 to 823 9 to 781       773/781
(98 %)
6 diff
(99.3 %id)
AL603356 human skeletal muscle .b 65 to 535 1 to 470       470/470
(100 %)
3 diff
(99.4 %id)
DA583874 lung .b 75 to 664 2 to 591   capped   590/590
(100 %)
1 diff
(99.9 %id)
DB139071 thymus .b 76 to 604 2 to 530   capped   529/529
(100 %)
0 diff
(100 %id)
DB163311 thymus .b 76 to 627 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DB278100 uterus .b 76 to 619 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
BX647592 heart .b 103 to 3495 1 to 3393 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 3393/3393
(100 %)
4 diff
(99.9 %id)
BC121053 PCR rescued clones .b 122 to 2587 1 to 2466 exact tiling clone,   2466/2466
(100 %)
1 diff
(100.0 %id)
BC121054 PCR rescued clones .b 122 to 2587 1 to 2466 M5T     2466/2466
(100 %)
2 diff
(100.0 %id)
BX114818 anaplastic oligodendroglioma, brain .b 164 to 629 1 to 466       466/466
(100 %)
0 diff
(100 %id)
AX721117   .b 547 to 1520 1 to 973       973/979
(99 %)
14 diff
(98.6 %id)
BE552137 Kidney .b 629 to 1209 584 to 1       584/584
(100 %)
5 diff
(99.2 %id)
BP306030   .b 638 to 1219 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
AW085543 pooled .b 701 to 1210 515 to 6       510/515
(99 %)
0 diff
(100 %id)
AI478173 Kidney .b 712 to 1192 481 to 1       481/481
(100 %)
14 diff
(97.1 %id)
AA969127 pooled .b 742 to 1190 444 to 1       444/444
(100 %)
7 diff
(98.5 %id)
AW340055 pooled .b 767 to 1210 444 to 1       444/444
(100 %)
2 diff
(99.6 %id)
AI279952 pooled .b 805 to 1210 406 to 1       406/406
(100 %)
0 diff
(100 %id)
AW450579   .b 806 to 1209 404 to 1       404/404
(100 %)
3 diff
(99.3 %id)
AI566850 anaplastic oligodendroglioma, brain .b 810 to 1210 401 to 1       401/401
(100 %)
3 diff
(99.3 %id)
AI364512 anaplastic oligodendroglioma, brain .b 828 to 1192 365 to 1       365/365
(100 %)
0 diff
(100 %id)
AW899376 nervous_normal .b 1414 to 2002 58 to 646       589/651
(90 %)
14 diff
(97.9 %id)
CB045618 colon, juvenile granulosa tumor .b 1632 to 2158 11 to 537     Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 527/537
(98 %)
6 diff
(98.9 %id)
BP305992   .b 2114 to 2694 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
CD708576 normal nasopharynx .b 2166 to 2530 22 to 385       364/385
(94 %)
6 diff
(98.5 %id)
BP422428 small intestine .b 2672 to 3176 1 to 505     Submitted on the opposite strand 505/505
(100 %)
1 diff
(99.9 %id)
CB045617 colon, juvenile granulosa tumor .b 3028 to 3495 489 to 22   tiling clone, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 468/468
(100 %)
0 diff
(100 %id)
AK299412 tongue .c 1 to 1368 2 to 1369 exact tiling clone,   1369/1369
(100 %)
0 diff
(100 %id)
DC373326 tongue .c 1 to 576 2 to 578       578/578
(100 %)
1 diff
(99.9 %id)
DA199955 brain .c 1 to 564 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
BG001310 placenta_normal .c 1260 to 1691 1 to 431   tiling clone,   431/431
(100 %)
6 diff
(98.7 %id)
BG001244 placenta_normal .c 1265 to 1691 1 to 425       425/425
(100 %)
6 diff
(98.6 %id)
BG001239 placenta_normal .c 1369 to 1691 323 to 1       323/323
(100 %)
4 diff
(98.8 %id)
BG001240 placenta_normal .c 1433 to 1931 508 to 3   tiling clone,   506/508
(99 %)
24 diff
(95.3 %id)
BG001243 placenta_normal .c 1435 to 1691 257 to 1       257/257
(100 %)
1 diff
(99.7 %id)
BG001308 placenta_normal .c 1435 to 1928 501 to 7   tiling clone,   495/505
(98 %)
4 diff
(99.3 %id)
DC341760 thalamus .d 1 to 575 1 to 575   tiling clone,   575/575
(100 %)
0 diff
(100 %id)
NM_015084.2   .d 1 to 2779 1 to 2779 exact RefSeq, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 2779/2779
(100 %)
0 diff
(100 %id)
DC346586 tongue, tumor tissue .d 3 to 567 1 to 565       565/565
(100 %)
0 diff
(100 %id)
DC354138 brain .d 3 to 571 1 to 569       569/569
(100 %)
0 diff
(100 %id)
DC375945 brain .d 8 to 590 1 to 583       583/583
(100 %)
0 diff
(100 %id)
DC393986 esophageal, tumor tissue .d 8 to 578 1 to 571       571/571
(100 %)
0 diff
(100 %id)
DC301652   .d 11 to 597 1 to 587       587/587
(100 %)
0 diff
(100 %id)
DC314459 amygdala .d 11 to 567 1 to 557       557/557
(100 %)
0 diff
(100 %id)
DC315097 amygdala .d 11 to 580 1 to 570       570/570
(100 %)
0 diff
(100 %id)
DC358018   .d 11 to 557 1 to 547       547/547
(100 %)
0 diff
(100 %id)
DC365010 esophagus .d 12 to 533 1 to 522       522/522
(100 %)
0 diff
(100 %id)
BJ993227 hepatoblastoma .d 17 to 523 1 to 507       507/507
(100 %)
0 diff
(100 %id)
AK025417 colon mucosa .d 18 to 2661 1 to 2644 exact tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 2644/2644
(100 %)
1 diff
(100.0 %id)
BP243673 Liver .d 18 to 592 1 to 575       575/575
(100 %)
0 diff
(100 %id)
DB193852 ovary, tumor tissue .d 18 to 567 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA023536   .d 19 to 578 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA481304   .d 19 to 563 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA484313 brain .d 19 to 548 2 to 531   capped   530/530
(100 %)
0 diff
(100 %id)
DA503231 brain .d 19 to 401 2 to 384   capped   383/383
(100 %)
0 diff
(100 %id)
CB141925 Liver .d 19 to 446 1 to 428       428/428
(100 %)
0 diff
(100 %id)
BM834161 stomach .d 19 to 456 1 to 438       438/438
(100 %)
0 diff
(100 %id)
DB257647 uterus .d 19 to 508 2 to 491   capped   490/490
(100 %)
0 diff
(100 %id)
DB274404 uterus .d 19 to 581 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA047020   .d 20 to 714 2 to 697   capped   696/696
(100 %)
4 diff
(99.5 %id)
DA081256 cerebellum .d 20 to 380 2 to 362   capped   361/361
(100 %)
0 diff
(100 %id)
DA434003 tongue, tumor tissue .d 20 to 533 2 to 515   capped   514/514
(100 %)
0 diff
(100 %id)
DA484127 brain .d 20 to 548 2 to 530   capped   529/529
(100 %)
0 diff
(100 %id)
DA596385   .d 20 to 580 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA611817   .d 20 to 596 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA616502   .d 20 to 597 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
AU121543 mammary gland .d 20 to 827 2 to 814   capped   813/813
(100 %)
13 diff
(98.5 %id)
DA660165   .d 20 to 590 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA665297   .d 20 to 574 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
AU124867   .d 20 to 870 2 to 847   capped   846/862
(98 %)
11 diff
(98.8 %id)
DA737965   .d 20 to 780 2 to 762   capped   761/761
(100 %)
4 diff
(99.5 %id)
DA772506 brain .d 20 to 590 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA775129 brain .d 20 to 565 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA784824 brain .d 20 to 608 2 to 590   capped   589/589
(100 %)
0 diff
(100 %id)
DA868031 Prostate .d 20 to 554 2 to 536   capped   535/535
(100 %)
0 diff
(100 %id)
DA918733 small intestine .d 20 to 593 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DB120537 thymus .d 20 to 573 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DB125721 thymus .d 20 to 533 2 to 515   capped   514/514
(100 %)
0 diff
(100 %id)
DA500224 brain .d 24 to 590 9 to 575   capped   567/567
(100 %)
0 diff
(100 %id)
DB504717 hypothalamus .d 24 to 504 1 to 481       481/481
(100 %)
0 diff
(100 %id)
DA042473 bladder .d 25 to 592 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA384138 thalamus .d 25 to 580 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA714917   .d 25 to 567 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DA589490 lung .d 26 to 565 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
BM788588 stomach .d 27 to 612 1 to 586       586/586
(100 %)
0 diff
(100 %id)
BM835675 stomach .d 27 to 602 1 to 576       576/576
(100 %)
0 diff
(100 %id)
DA023882   .d 28 to 619 2 to 593   capped   592/592
(100 %)
0 diff
(100 %id)
DA025616   .d 28 to 596 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA137430 alzheimer cortex .d 28 to 582 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
AL536034 brain, fetal brain .d 28 to 957 1 to 930       930/930
(100 %)
0 diff
(100 %id)
DA521838 brain .d 28 to 582 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA556066   .d 28 to 553 2 to 527   capped   526/526
(100 %)
0 diff
(100 %id)
AU129452   .d 28 to 742 2 to 719   capped   718/726
(98 %)
18 diff
(97.6 %id)
AU133298   .d 28 to 870 2 to 845   capped   844/863
(97 %)
9 diff
(99.0 %id)
DA741531   .d 28 to 580 15 to 567   capped   553/553
(100 %)
0 diff
(100 %id)
DA768449 brain .d 28 to 533 2 to 507   capped   506/506
(100 %)
0 diff
(100 %id)
DA874653 Prostate .d 28 to 588 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DB127421 thymus .d 28 to 565 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
DA010610 adrenal gland .d 30 to 591 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
BC064902 Lung, large cell carcinoma .d 30 to 2661 1 to 2632 exact available from MGC, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 2632/2632
(100 %)
1 diff
(100.0 %id)
DA106441 cerebellum .d 30 to 592 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA353304 substantia nigra .d 30 to 603 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA508130 brain .d 30 to 601 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA562792 heart .d 30 to 606 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA600692   .d 30 to 600 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA665494   .d 30 to 584 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA666670   .d 30 to 578 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA747964   .d 30 to 577 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DB272888 uterus .d 30 to 597 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
AL528293 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 31 to 1039 1 to 1004       1004/1004
(100 %)
10 diff
(99.1 %id)
BP247307 Kidney .d 31 to 613 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BQ049800 lymph, lymphoma, cell line .d 31 to 977 1 to 952       952/1048
(90 %)
24 diff
(97.8 %id)
D87453 bone marrow .d 32 to 2666 1 to 2635 G284D available from KIAA,   2635/2635
(100 %)
2 diff
(100.0 %id)
BM479868 embryonal carcinoma, cell line, testis .d 32 to 1042 1 to 1023       1023/1045
(97 %)
25 diff
(97.7 %id)
AL529376 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .d 33 to 1042 1 to 1002       1002/1091
(91 %)
11 diff
(99.0 %id)
BM458362 lymph, lymphoma, cell line .d 33 to 1125 1 to 1095       1095/1100
(99 %)
25 diff
(97.8 %id)
CV810811 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 34 to 754 1 to 721       721/721
(100 %)
1 diff
(99.9 %id)
DA204054 brain .d 35 to 617 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
DA207243 brain .d 35 to 606 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA494752 brain .d 35 to 612 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DA509189 brain .d 35 to 597 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA599090   .d 35 to 595 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA770384 brain .d 35 to 616 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
DA771742 brain .d 35 to 606 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA883200   .d 35 to 602 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA939777 Spleen .d 35 to 608 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA942514 Spleen .d 35 to 622 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
DB088351 testis .d 35 to 591 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DB126269 thymus .d 35 to 606 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DB202820 trachea .d 35 to 613 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
CN419207 embryonic stem cells, DMSO-treated H9 cellline .d 36 to 789 1 to 754       754/754
(100 %)
0 diff
(100 %id)
AL527374 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 36 to 922 1 to 886       886/886
(100 %)
1 diff
(99.9 %id)
EL735098 mixed .d 37 to 659 1 to 623       623/623
(100 %)
0 diff
(100 %id)
TI_1948216086   .d 37 to 658 135 to 756   fully sequenced,   622/756
(82 %)
6 diff
(99.3 %id)
TI_1948216247   .d 37 to 658 132 to 753   fully sequenced, AAA   622/753
(82 %)
6 diff
(99.3 %id)
TI_1948216405   .d 37 to 658 134 to 755   fully sequenced,   622/755
(82 %)
6 diff
(99.3 %id)
TI_1948216564   .d 37 to 658 132 to 753   fully sequenced,   622/753
(82 %)
6 diff
(99.3 %id)
BM560560 astrocytoma grade IV, cell line, brain .d 40 to 870 1 to 830       830/1096
(75 %)
12 diff
(99.0 %id)
BM549703 astrocytoma grade IV, cell line, brain .d 40 to 979 1 to 945       945/1005
(94 %)
19 diff
(98.2 %id)
BM802103 duodenal adenocarcinoma, cell line, small intestine .d 47 to 873 1 to 833       833/946
(88 %)
16 diff
(98.4 %id)
BQ961919 epithelioid carcinoma cell line, Pancreas .d 48 to 814 1 to 774       774/856
(90 %)
8 diff
(99.1 %id)
BQ232024 embryonal carcinoma, cell line, testis .d 49 to 857 1 to 815       815/900
(90 %)
7 diff
(99.3 %id)
CX760612 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 49 to 807 1 to 757     Submitted on the opposite strand 757/800
(94 %)
5 diff
(99.4 %id)
BQ054932 lymph, lymphoma, cell line .d 58 to 873 1 to 820       820/1132
(72 %)
16 diff
(98.6 %id)
BQ056274 lymph, lymphoma, cell line .d 58 to 1039 1 to 983       983/1001
(98 %)
24 diff
(97.7 %id)
BQ057960 lymph, lymphoma, cell line .d 58 to 1040 1 to 987       987/1041
(94 %)
15 diff
(98.6 %id)
BQ059868 lymph, lymphoma, cell line .d 58 to 873 1 to 825       825/1013
(81 %)
11 diff
(99.0 %id)
BM456405 lymph, lymphoma, cell line .d 60 to 867 1 to 818       818/852
(96 %)
13 diff
(98.5 %id)
BU521865 leiomyosarcoma, uterus .d 65 to 873 1 to 812       812/866
(93 %)
5 diff
(99.5 %id)
BE271894 adenocarcinoma cell line, ovary .d 66 to 562 1 to 497       497/497
(100 %)
0 diff
(100 %id)
DA710182   .d 66 to 605 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
CR988284 T-Lymphocytes .d 67 to 852 1 to 788       788/788
(100 %)
2 diff
(99.8 %id)
AL557650 T cells (Jurkat cell line), T cells from T cell leukemia .d 71 to 769 1 to 699       699/699
(100 %)
1 diff
(99.9 %id)
DA525402 brain .d 165 to 733 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
AU138645 placenta .d 170 to 931 2 to 767   capped   766/766
(100 %)
7 diff
(99.1 %id)
BQ056927 lymph, lymphoma, cell line .d 182 to 1146 1 to 977       975/998
(97 %)
29 diff
(97.1 %id)
BQ066461 lymph, lymphoma, cell line .d 184 to 1134 1 to 957       957/965
(99 %)
20 diff
(98.0 %id)
DA453027 tongue, tumor tissue .d 253 to 816 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
AU125273   .d 255 to 1075 2 to 825   capped   824/825
(99 %)
8 diff
(99.1 %id)
CB140292 Liver .d 290 to 730 1 to 441       441/441
(100 %)
0 diff
(100 %id)
DB253945 uterus .d 438 to 999 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA544110   .d 458 to 1027 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
BQ439409 embryonal carcinoma, cell line, testis .d 460 to 1325 1 to 872       872/873
(99 %)
8 diff
(99.1 %id)
AU121600 mammary gland .d 476 to 1268 2 to 797   capped   796/797
(99 %)
6 diff
(99.3 %id)
BQ433682 embryonal carcinoma, cell line, testis .d 482 to 1300 1 to 824       824/834
(98 %)
10 diff
(98.9 %id)
DA487600 brain .d 507 to 1063 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA601300   .d 522 to 839 2 to 319   capped   318/318
(100 %)
0 diff
(100 %id)
BX458574 placenta .d 524 to 1480 1 to 953       953/953
(100 %)
10 diff
(99.0 %id)
BM543211 embryonal carcinoma, cell line, testis .d 536 to 1557 1 to 1032       1032/1126
(91 %)
42 diff
(96.3 %id)
BM046798 carcinoma, cell line, Prostate .d 569 to 1499 1 to 926       926/926
(100 %)
26 diff
(97.2 %id)
BM048829 carcinoma, cell line, Prostate .d 569 to 1533 1 to 962       962/973
(98 %)
37 diff
(96.2 %id)
CV574337 cornea, eye .d 570 to 1072 1 to 503       503/503
(100 %)
0 diff
(100 %id)
BQ927292 large cell carcinoma, lung .d 591 to 1488 1 to 909       909/914
(99 %)
22 diff
(97.6 %id)
TI_1948216087   .d 597 to 1280 807 to 124   fully sequenced,   684/807
(84 %)
0 diff
(100 %id)
TI_1948216248   .d 597 to 1280 807 to 123   fully sequenced,   685/807
(84 %)
0 diff
(100 %id)
TI_1948216406   .d 597 to 1280 807 to 125   fully sequenced,   683/807
(84 %)
0 diff
(100 %id)
TI_1948216565   .d 597 to 1280 805 to 123   fully sequenced,   683/805
(84 %)
0 diff
(100 %id)
BC030521 Colon, Kidney, Stomach, adult, whole pooled .d 600 to 2664 54 to 2117   available from MGC, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 2064/2117
(97 %)
9 diff
(99.6 %id)
BC003632 Skin, melanotic melanoma. .d 611 to 2664 1 to 2054   available from MGC, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 2054/2054
(100 %)
0 diff
(100 %id)
BE303067 melanotic melanoma, skin .d 612 to 1194 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
BU848646 ovary, teratocarcinoma, cell line .d 619 to 1512 1 to 895       895/909
(98 %)
2 diff
(99.8 %id)
AK027001   .d 628 to 2661 1 to 2033   available from FLJ, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 2033/2033
(100 %)
2 diff
(100.0 %id)
BE728569 melanotic melanoma, skin .d 628 to 1427 1 to 802       802/805
(99 %)
25 diff
(96.9 %id)
BE742435 adenocarcinoma cell line, ovary .d 660 to 1473 1 to 811       811/860
(94 %)
29 diff
(96.7 %id)
BI259691 cervical carcinoma cell line, cervix .d 680 to 1609 1 to 935       935/936
(99 %)
18 diff
(98.1 %id)
DA750616   .d 701 to 1225 2 to 526   capped   525/525
(100 %)
0 diff
(100 %id)
BQ226096 melanotic melanoma, skin .d 717 to 1611 1 to 900       900/901
(99 %)
18 diff
(98.1 %id)
AW878322 ovary .d 859 to 1499 10 to 650       641/650
(98 %)
7 diff
(99.0 %id)
AW886101 ovary .d 859 to 1499 10 to 650       641/650
(98 %)
7 diff
(99.0 %id)
AW886185 ovary .d 859 to 1452 10 to 603       594/603
(98 %)
6 diff
(99.1 %id)
AW886286 ovary .d 859 to 1333 10 to 484       475/484
(98 %)
6 diff
(98.8 %id)
AW887888 ovary .d 859 to 1333 10 to 484       475/484
(98 %)
6 diff
(98.8 %id)
BE017979 cervical carcinoma cell line, cervix .d 869 to 1411 1 to 543       543/543
(100 %)
0 diff
(100 %id)
BQ652105 hepatocellular carcinoma, cell line, Liver .d 928 to 1761 1 to 842       842/968
(86 %)
18 diff
(98.2 %id)
DA356067 subthalamic nucleus .d 951 to 1513 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
CD626667   .d 955 to 1641 686 to 1       686/686
(100 %)
8 diff
(98.9 %id)
CR592628 Placenta Cot 25-normalized .d 967 to 2633 1 to 1667       1667/1667
(100 %)
0 diff
(100 %id)
AL551544 placenta, Placenta Cot 25-normalized .d 967 to 1676 1 to 700   fully sequenced,   700/700
(100 %)
1 diff
(99.9 %id)
BQ643722 hepatocellular carcinoma, cell line, Liver .d 1004 to 1938 1 to 935       935/937
(99 %)
12 diff
(98.8 %id)
BQ651861 hepatocellular carcinoma, cell line, Liver .d 1004 to 1863 1 to 869       869/908
(95 %)
30 diff
(96.7 %id)
BQ645078 hepatocellular carcinoma, cell line, Liver .d 1005 to 1926 1 to 932       932/965
(96 %)
32 diff
(96.7 %id)
BM555628 duodenal adenocarcinoma, cell line, small intestine .d 1037 to 2026 1 to 998       998/1026
(97 %)
20 diff
(98.1 %id)
CD626669   .d 1069 to 1641 573 to 1       573/574
(99 %)
0 diff
(100 %id)
CD626665   .d 1073 to 1641 571 to 1       571/576
(99 %)
2 diff
(99.7 %id)
BQ225995 large cell carcinoma, lung .d 1099 to 2027 1 to 929       929/929
(100 %)
7 diff
(99.3 %id)
BQ937319 epidermoid carcinoma, cell line, lung .d 1161 to 2082 1 to 926       926/927
(99 %)
12 diff
(98.8 %id)
CB137882 Liver .d 1198 to 1445 1 to 248       248/248
(100 %)
0 diff
(100 %id)
BE833243 ovary .d 1269 to 1592 332 to 8       325/332
(97 %)
0 diff
(100 %id)
BU859045 ovary, teratocarcinoma, cell line .d 1287 to 2201 1 to 924       924/926
(99 %)
9 diff
(99.1 %id)
CN419202 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 1311 to 1819 1 to 509       509/509
(100 %)
0 diff
(100 %id)
T55537 fetal spleen, Spleen .d 1340 to 1500 1 to 161       161/161
(100 %)
0 diff
(100 %id)
BQ054430 lymph, lymphoma, cell line .d 1409 to 2253 1 to 846       846/1039
(81 %)
11 diff
(99.0 %id)
BQ065466 lymph, lymphoma, cell line .d 1409 to 2325 1 to 937       937/1049
(89 %)
40 diff
(96.2 %id)
BU849291 mixed (pool of 40 RNAs) .d 1437 to 2332 1 to 908       908/912
(99 %)
42 diff
(95.4 %id)
BX284050 skin, squamous cell carcinoma .d 1451 to 1963 1 to 513       513/513
(100 %)
0 diff
(100 %id)
BG676018 skin, squamous cell carcinoma .d 1451 to 2347 1 to 896       896/896
(100 %)
8 diff
(99.2 %id)
CN419209 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 1475 to 1767 1 to 293       293/293
(100 %)
0 diff
(100 %id)
BG001311 placenta_normal .d 1553 to 2142 590 to 1       590/590
(100 %)
14 diff
(97.7 %id)
BF836159 head_neck .d 1556 to 1899 345 to 1     Submitted on the opposite strand 345/346
(99 %)
10 diff
(97.2 %id)
AL563430 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .d 1564 to 2645 1074 to 1       1074/1100
(97 %)
35 diff
(96.9 %id)
BF836163 head_neck .d 1634 to 2138 518 to 2     Submitted on the opposite strand 517/518
(99 %)
26 diff
(95.0 %id)
AL575079 placenta, Placenta Cot 25-normalized .d 1646 to 2633 978 to 1   fully sequenced,   978/978
(100 %)
10 diff
(99.0 %id)
AL536033 brain, fetal brain .d 1658 to 2633 978 to 1       978/981
(99 %)
10 diff
(99.0 %id)
AL528292 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 1677 to 2331 959 to 304       656/687
(95 %)
27 diff
(96.1 %id)
AL527324 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 1694 to 2633 943 to 1       943/943
(100 %)
9 diff
(99.1 %id)
CD672669 eye, Iris .d 1735 to 2376 1 to 642       642/642
(100 %)
0 diff
(100 %id)
AL579639 T cells (Jurkat cell line), T cells from T cell leukemia .d 1881 to 2643 763 to 1       763/763
(100 %)
12 diff
(98.5 %id)
AW749360 breast .d 1884 to 2292 1 to 409       409/409
(100 %)
2 diff
(99.6 %id)
AW819759 stomach .d 1884 to 2292 1 to 406       406/406
(100 %)
5 diff
(98.8 %id)
EL954168 eyeball .d 1902 to 2477 1 to 576       576/576
(100 %)
0 diff
(100 %id)
AA360187   .d 1910 to 2246 1 to 335       335/340
(98 %)
6 diff
(98.3 %id)
AA721761 Ewing's sarcoma .d 1915 to 2286 1 to 371       371/371
(100 %)
8 diff
(97.9 %id)
CF455765 peripheral nervous system .d 1915 to 2370 31 to 486       456/786
(58 %)
1 diff
(99.9 %id)
BF836173 head_neck .d 1916 to 2131 217 to 1     Submitted on the opposite strand 217/217
(100 %)
3 diff
(98.7 %id)
BF836174 head_neck .d 1916 to 2139 226 to 3     Submitted on the opposite strand 224/226
(99 %)
0 diff
(100 %id)
BG001233 placenta_normal .d 1916 to 2136 227 to 7       221/227
(97 %)
0 diff
(100 %id)
BG001242 placenta_normal .d 1916 to 2136 228 to 7       222/228
(97 %)
0 diff
(100 %id)
BG001304 placenta_normal .d 1916 to 2139 226 to 3       224/226
(99 %)
0 diff
(100 %id)
BG001316 placenta_normal .d 1916 to 2139 227 to 3       225/227
(99 %)
0 diff
(100 %id)
BI041295 nervous_tumor .d 1916 to 2245 330 to 1       330/330
(100 %)
0 diff
(100 %id)
BI041889 nervous_tumor .d 1916 to 2217 1 to 302       302/302
(100 %)
2 diff
(99.4 %id)
CN335006 embryonic stem cells, DMSO-treated H9 cellline .d 1928 to 2443 1 to 516       516/516
(100 %)
4 diff
(99.3 %id)
BE077066 breast .d 1935 to 2291 1 to 357       357/388
(92 %)
5 diff
(98.8 %id)
AA721714 Ewing's sarcoma .d 1936 to 2373 22 to 458       437/458
(95 %)
6 diff
(98.7 %id)
BQ332473 lung_tumor .d 1939 to 2245 14 to 318       305/318
(95 %)
6 diff
(98.2 %id)
BQ332494 lung_tumor .d 1939 to 2245 14 to 318       305/318
(95 %)
6 diff
(98.2 %id)
BQ368908 placenta_normal .d 1954 to 2221 1 to 269       269/269
(100 %)
10 diff
(96.3 %id)
BI016937 lung_tumor .d 1965 to 2203 1 to 239       239/239
(100 %)
4 diff
(98.4 %id)
BF809152 colon_ins .d 2016 to 2245 230 to 1     Submitted on the opposite strand 230/230
(100 %)
1 diff
(99.6 %id)
AU151563   .d 2084 to 2661 575 to 1       575/578
(99 %)
10 diff
(98.3 %id)
AU147384 mammary gland .d 2088 to 2661 572 to 1       572/575
(99 %)
4 diff
(99.4 %id)
AU154666   .d 2096 to 2661 566 to 1       566/566
(100 %)
6 diff
(99.0 %id)
DB324068   .d 2106 to 2661 556 to 1       556/556
(100 %)
1 diff
(99.9 %id)
FN167111 breast carcinoma .d 2109 to 2209 100 to 1     Submitted on the opposite strand 100/105
(95 %)
1 diff
(99.1 %id)
BE811098 amnion_normal .d 2114 to 2442 1 to 329       329/329
(100 %)
2 diff
(99.4 %id)
BE773235 prostate_tumor .d 2131 to 2453 1 to 324       324/329
(98 %)
7 diff
(97.9 %id)
AU147332 mammary gland .d 2131 to 2661 533 to 1       533/538
(99 %)
11 diff
(98.0 %id)
CB146888 Liver .d 2144 to 2661 539 to 22   AAA Submitted on the opposite strand 518/518
(100 %)
0 diff
(100 %id)
BE300762 melanotic melanoma, skin .d 2162 to 2664 505 to 3       503/505
(99 %)
0 diff
(100 %id)
FN107039 breast carcinoma .d 2183 to 2290 1 to 107       107/107
(100 %)
3 diff
(97.2 %id)
AU148649   .d 2188 to 2664 477 to 1       477/477
(100 %)
0 diff
(100 %id)
AU157688 placenta .d 2190 to 2666 476 to 1       476/479
(99 %)
4 diff
(99.2 %id)
EC468616 Prostate .d 2193 to 2311 1 to 119       119/122
(97 %)
8 diff
(93.5 %id)
EC467961 Prostate .d 2197 to 2310 1 to 107       107/109
(98 %)
8 diff
(92.7 %id)
AA838664 epithelium (cell line), Prostate .d 2210 to 2661 452 to 1       452/452
(100 %)
2 diff
(99.6 %id)
DB370582   .d 2235 to 2779 542 to 1       542/542
(100 %)
7 diff
(98.8 %id)
DB362951   .d 2245 to 2779 539 to 1   tiling clone,   539/540
(99 %)
16 diff
(97.1 %id)
AI367971 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .d 2257 to 2662 406 to 1       406/406
(100 %)
0 diff
(100 %id)
BF809148 colon_ins .d 2260 to 2508 266 to 18     Submitted on the opposite strand 249/266
(93 %)
0 diff
(100 %id)
AI168311 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 2298 to 2658 361 to 1       361/361
(100 %)
0 diff
(100 %id)
BG942571 blood .d 2305 to 2659 386 to 33   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 354/356
(99 %)
0 diff
(100 %id)
T03460   .d 2321 to 2661 341 to 1       341/341
(100 %)
0 diff
(100 %id)
FN148334 breast carcinoma .d 2325 to 2393 1 to 69       69/70
(98 %)
1 diff
(98.6 %id)
FN071445 breast carcinoma .d 2326 to 2405 80 to 1     Submitted on the opposite strand 80/81
(98 %)
2 diff
(97.6 %id)
FN078151 breast carcinoma .d 2326 to 2405 78 to 1     Submitted on the opposite strand 78/79
(98 %)
3 diff
(96.3 %id)
FN102717 breast carcinoma .d 2327 to 2385 1 to 58       58/58
(100 %)
1 diff
(98.3 %id)
AA746737 alveolar rhabdomyosarcoma .d 2336 to 2662 330 to 6       325/333
(97 %)
0 diff
(100 %id)
AA894725 Kidney .d 2398 to 2661 264 to 1       264/264
(100 %)
0 diff
(100 %id)
F00406 leg muscle, skeletal muscle .d 2429 to 2631 203 to 1       203/203
(100 %)
0 diff
(100 %id)
T33742 brain .d 2437 to 2661 225 to 1       225/225
(100 %)
0 diff
(100 %id)
FN157067 breast carcinoma .d 2450 to 2548 100 to 1     Submitted on the opposite strand 100/103
(97 %)
3 diff
(97.1 %id)
FN091149 breast carcinoma .d 2507 to 2606 96 to 2     Submitted on the opposite strand 95/96
(98 %)
0 diff
(100 %id)
FN077483 breast carcinoma .d 2527 to 2628 104 to 1     Submitted on the opposite strand 104/105
(99 %)
1 diff
(99.1 %id)
BE270503 Burkitt lymphoma, lymph .e 1 to 601 10 to 611   available from MGC,   602/611
(98 %)
6 diff
(99.1 %id)
DC370478   .e 1 to 543 1 to 543   tiling clone,   543/543
(100 %)
0 diff
(100 %id)
DC414500 trachea .e 1 to 477 1 to 477       477/477
(100 %)
0 diff
(100 %id)
DC334624 hippocampus .e 2 to 571 1 to 570       570/570
(100 %)
0 diff
(100 %id)
DC346401 tongue, tumor tissue .e 2 to 556 1 to 556       556/556
(100 %)
2 diff
(99.7 %id)
DC351220 brain .e 2 to 583 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
DC380592 placenta .e 2 to 548 1 to 547       547/547
(100 %)
0 diff
(100 %id)
BM833811 stomach .e 2 to 628 1 to 627       627/627
(100 %)
1 diff
(99.9 %id)
BM835063 stomach .e 3 to 446 1 to 444       444/444
(100 %)
2 diff
(99.6 %id)
DC374606 brain .e 6 to 581 1 to 576       576/576
(100 %)
1 diff
(99.9 %id)
BM749180 stomach .e 7 to 632 13 to 638   tiling clone,   626/638
(98 %)
6 diff
(99.1 %id)
DC341804 thalamus .e 10 to 585 1 to 576       576/576
(100 %)
0 diff
(100 %id)
DC349434   .e 10 to 566 1 to 557       557/557
(100 %)
0 diff
(100 %id)
BE269048 Burkitt lymphoma, lymph .e 10 to 607 27 to 625       599/625
(95 %)
9 diff
(98.6 %id)
DC363254   .e 10 to 506 1 to 498       498/498
(100 %)
1 diff
(99.8 %id)
DC376231 brain .e 10 to 581 1 to 572       572/572
(100 %)
1 diff
(99.9 %id)
BP344810 synovial membrane .e 10 to 593 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
DC326143 caudate nucleus .e 12 to 574 1 to 563       563/563
(100 %)
0 diff
(100 %id)
DC375610 brain .e 12 to 589 1 to 578       578/578
(100 %)
0 diff
(100 %id)
DC379402 pericardium .e 17 to 578 1 to 563       563/571
(98 %)
1 diff
(99.9 %id)
DC391124 Spleen .e 17 to 567 1 to 551       551/551
(100 %)
0 diff
(100 %id)
BQ959641 leiomyosarcoma, uterus .e 553 to 1463 36 to 958   tiling clone,   923/959
(96 %)
28 diff
(97.1 %id)
DC299526   .f -8 to 554 1 to 563   tiling clone,   563/563
(100 %)
1 diff
(99.9 %id)
AL556800 placenta .f 9 to 964 1 to 958   tiling clone,   958/958
(100 %)
2 diff
(99.8 %id)
BU180662 eye, retinoblastoma .f 12 to 856 1 to 849   tiling clone,   849/882
(96 %)
5 diff
(99.5 %id)
AL579057 placenta .f 1514 to 2480 982 to 14   tiling clone,   969/982
(98 %)
0 diff
(100 %id)
DC350259 brain .g 1 to 567 1 to 568   tiling clone,   568/568
(100 %)
2 diff
(99.7 %id)
DC375309 brain .g 25 to 590 1 to 566       566/566
(100 %)
1 diff
(99.9 %id)
DC420388 uterus .g 82 to 665 1 to 584       584/584
(100 %)
1 diff
(99.9 %id)
DC420565 uterus .g 84 to 653 1 to 571       571/571
(100 %)
3 diff
(99.5 %id)
AK300111 pericardium .g 88 to 1659 1 to 1572 S13P D329N     1572/1572
(100 %)
3 diff
(99.9 %id)
DC379940 pericardium .g 88 to 658 1 to 572       572/572
(100 %)
3 diff
(99.5 %id)
DC379949 pericardium .g 88 to 553 1 to 468       466/468
(99 %)
4 diff
(99.2 %id)
DC384823   .g 97 to 646 1 to 551       551/551
(100 %)
1 diff
(99.9 %id)
DC424267.
matches multiple genes
  .g 105 to 784 15 to 702     also hits gene SLC2A1 688/735
(93 %)
22 diff
(97.1 %id)
AU127667   .g 105 to 760 15 to 671   capped   657/664
(98 %)
17 diff
(97.5 %id)
BC011818 Lymph, Burkitt lymphoma .g 113 to 2714 1 to 2602 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 2602/2602
(100 %)
1 diff
(100.0 %id)
BG031247 breast, mammary adenocarcinoma, cell line .g 115 to 872 1 to 754       754/905
(83 %)
22 diff
(97.6 %id)
AU131101   .g 120 to 949 2 to 830   capped   829/829
(100 %)
8 diff
(99.1 %id)
BI226950 Burkitt lymphoma, lymph .g 122 to 784 1 to 664       666/671
(99 %)
16 diff
(97.7 %id)
AU152924   .g 2145 to 2714 567 to 1   tiling clone,   567/574
(98 %)
19 diff
(96.7 %id)
AU150175   .g 2159 to 2714 553 to 1       553/555
(99 %)
13 diff
(97.7 %id)
CN419208 embryonic stem cells, cell lines H1, H7, andH9 .h 1 to 718 1 to 721   tiling clone,   721/721
(100 %)
7 diff
(99.1 %id)
BF796953 lymph, lymphoma, cell line .h 19 to 718 1 to 709       707/1020
(69 %)
25 diff
(97.6 %id)
DA038852   .h 349 to 922 2 to 575   tiling clone, capped   574/574
(100 %)
0 diff
(100 %id)
DC376096 brain .i 1 to 441 12 to 452       445/475
(93 %)
1 diff
(99.8 %id)
DC395600 testis .i 1 to 574 2 to 575   tiling clone,   575/575
(100 %)
0 diff
(100 %id)
DC375800 brain .i 6 to 584 1 to 582       582/583
(99 %)
10 diff
(98.3 %id)
DC298598 adrenal gland .i 7 to 577 1 to 571       571/571
(100 %)
0 diff
(100 %id)
DC347152 tongue, tumor tissue .i 7 to 564 1 to 559       559/559
(100 %)
1 diff
(99.9 %id)
BP308783 brain .i 7 to 593 1 to 588       586/588
(99 %)
1 diff
(99.9 %id)
DC375448 brain .i 7 to 589 1 to 583       583/583
(100 %)
0 diff
(100 %id)
DC391601 Spleen .i 7 to 471 1 to 466       466/466
(100 %)
1 diff
(99.8 %id)
BF686217 leiomyosarcoma cell line, uterus .i 17 to 750 1 to 735       735/1056
(69 %)
24 diff
(97.8 %id)
DC394989 testis .i 22 to 594 1 to 573       573/573
(100 %)
2 diff
(99.7 %id)
DB446475 testis .i 24 to 441 1 to 419       419/446
(93 %)
13 diff
(97.1 %id)
DC419480 uterus, tumor tissue .i 24 to 572 1 to 549       549/549
(100 %)
1 diff
(99.9 %id)
AK310474 testis .i 434 to 1269 445 to 1280   tiling clone,   836/1280
(65 %)
8 diff
(99.4 %id)
AK309065 hippocampus .j 1 to 1183 1 to 1183 exact tiling clone,   1183/1183
(100 %)
1 diff
(100.0 %id)
DR157285 human embryonic stem cells differentiated toan early endodermal cell type .j 381 to 1063 10 to 692   tiling clone,   684/692
(98 %)
6 diff
(99.2 %id)
AW500575 lymph .j 1172 to 1780 1 to 609       609/609
(100 %)
3 diff
(99.6 %id)
TI_154150099   .j 1179 to 1969 80 to 864       785/789
(99 %)
65 diff
(91.8 %id)
TI_154154828   .j 1179 to 1810 81 to 712   tiling clone,   632/632
(100 %)
0 diff
(100 %id)
CN287468 embryonic stem cells, cell lines H1, H7, andH9 .j 1419 to 2076 1 to 657   tiling clone,   657/657
(100 %)
2 diff
(99.7 %id)
BM785618 Ascites, stomach .k 1 to 647 1 to 647   tiling clone,   647/647
(100 %)
1 diff
(99.9 %id)
DC304988 cerebellum .k 20 to 586 1 to 567       567/567
(100 %)
1 diff
(99.9 %id)
AK296581 cervix .k 170 to 1400 1 to 1231 W32R tiling clone,   1231/1231
(100 %)
2 diff
(99.9 %id)
DC344609 cervix .k 170 to 744 1 to 575       575/575
(100 %)
1 diff
(99.9 %id)
CN419205 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .k 200 to 895 1 to 696       696/696
(100 %)
1 diff
(99.9 %id)
AK128683 uterus .l 1 to 4434 2 to 4436 exact tiling clone, available from FLJ,   4436/4436
(100 %)
2 diff
(100.0 %id)
DB280002 uterus .l 1 to 509 2 to 511   capped   510/510
(100 %)
1 diff
(99.9 %id)
EL593418 epidermis, skin .l 167 to 822 663 to 16     Submitted on the opposite strand 648/738
(87 %)
0 diff
(100 %id)
AW500964 lymph .l 1027 to 1510 8 to 491       484/491
(98 %)
6 diff
(98.8 %id)
AW501495 lymph .l 1027 to 1386 8 to 367       360/367
(98 %)
6 diff
(98.4 %id)
CF143898 lymph .l 1027 to 1382 8 to 363       356/363
(98 %)
6 diff
(98.4 %id)
CF121919 lymph .l 1027 to 1699 8 to 679       672/679
(98 %)
7 diff
(99.0 %id)
TI_154155464   .l 1027 to 1530 80 to 583       504/504
(100 %)
0 diff
(100 %id)
TI_154156398   .l 1027 to 1590 80 to 643       564/608
(92 %)
23 diff
(96.3 %id)
TI_154175572   .l 1027 to 1438 80 to 491       412/412
(100 %)
6 diff
(98.6 %id)
TI_154181282   .l 1027 to 1879 76 to 929       854/854
(100 %)
10 diff
(98.9 %id)
DB152462 thymus .l 1645 to 2235 2 to 592   capped   591/591
(100 %)
1 diff
(99.9 %id)
BU429165 lymph .l 1779 to 2246 1 to 468       468/468
(100 %)
7 diff
(98.6 %id)
DA934739 Spleen .l 2060 to 2614 2 to 556   tiling clone, capped   555/555
(100 %)
0 diff
(100 %id)
DB346229 thymus .l 3897 to 4434 538 to 1   tiling clone,   538/539
(99 %)
2 diff
(99.7 %id)
DB352418 uterus .l 3922 to 4434 514 to 1       514/514
(100 %)
3 diff
(99.5 %id)
DA410990 thalamus .m-u 1 to 567 2 to 568 exact tiling clone, capped   567/567
(100 %)
1 diff
(99.9 %id)
DA956389 Spleen .m-u 2 to 566 2 to 566 exact capped   565/565
(100 %)
0 diff
(100 %id)
DB092316 testis .m-u 8 to 555 2 to 550 G17W E18R R19E E20R V21G ... capped   549/549
(100 %)
1 diff
(99.9 %id)
AK095964   .m-u 51 to 2462 1 to 2411 exact tiling clone, available from FLJ,   2411/2411
(100 %)
4 diff
(99.9 %id)
DA577906   .m-u 52 to 619 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DA292318 hippocampus .m-u 81 to 657 2 to 578   capped   577/589
(97 %)
0 diff
(100 %id)
DA178459 amygdala .m-u 154 to 657 2 to 505   capped   504/516
(97 %)
0 diff
(100 %id)
DB318967   .m-u 1926 to 2462 538 to 1       538/538
(100 %)
2 diff
(99.7 %id)
DA885252   .n 1 to 549 2 to 550 exact tiling clone, capped   549/549
(100 %)
0 diff
(100 %id)
DA156340 amygdala .n 377 to 909 2 to 534   tiling clone, capped   533/537
(99 %)
3 diff
(99.5 %id)
DA064767 cerebellum .o 1 to 577 2 to 579 exact tiling clone, capped   578/578
(100 %)
2 diff
(99.7 %id)
DC318930 brain .p 1 to 528 1 to 529 K102Q D103R A104C L105F tiling clone,   529/529
(100 %)
4 diff
(99.3 %id)
AI739305 colon, colon tumor, RER+ .q 1 to 486 486 to 1 exact tiling clone,   486/486
(100 %)
0 diff
(100 %id)
AW772634 Kidney .q 34 to 479 454 to 9       446/454
(98 %)
0 diff
(100 %id)
DA279255 corpus callosum .r 1 to 570 2 to 573   tiling clone, capped   572/572
(100 %)
2 diff
(99.7 %id)
AW407676 lymph .r 126 to 523 9 to 406   tiling clone,   397/406
(97 %)
6 diff
(98.6 %id)
CN419214 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .r 194 to 316 1 to 123       123/123
(100 %)
0 diff
(100 %id)
AL119775 amygdala .s 1 to 504 1 to 504 exact tiling clone,   504/504
(100 %)
0 diff
(100 %id)
AL597409   .s 2 to 467 1 to 466 K26X     466/466
(100 %)
2 diff
(99.6 %id)
AK090694 cerebellum .t-u 1 to 2488 2 to 2488 W50* tiling clone, available from FLJ,   2488/2488
(100 %)
7 diff
(99.8 %id)
DA058399 cerebellum .t-u 1 to 545 2 to 545   capped   544/544
(100 %)
2 diff
(99.7 %id)
DA181839 amygdala .t-u 27 to 591 2 to 565   capped   564/564
(100 %)
2 diff
(99.7 %id)
CA395230 eye, RPE/choroid .t-u 306 to 771 1 to 465       465/465
(100 %)
2 diff
(99.6 %id)
BI820610 pooled brain, lung, testis .t-u 547 to 1271 1 to 729       729/729
(100 %)
20 diff
(97.3 %id)
TI_57197834   .t-u 547 to 1271 35 to 763       729/763
(95 %)
6 diff
(99.3 %id)
CV332134 head_neck .t-u 788 to 1445 16 to 672 exact tiling clone,   657/672
(97 %)
7 diff
(99.0 %id)
BF996277 placenta_normal .t-u 808 to 988 360 to 542       183/542
(33 %)
7 diff
(98.8 %id)
CV416188 placenta_normal .t-u 852 to 1196 357 to 9     Submitted on the opposite strand 349/357
(97 %)
0 diff
(100 %id)
R33356 placenta .t-u 1105 to 1480 1 to 393 exact tiling clone,   393/395
(99 %)
21 diff
(94.7 %id)
BE169336 head_neck .t-u 1633 to 2016 385 to 3     Submitted on the opposite strand 383/388
(98 %)
0 diff
(100 %id)
AW072430 pooled .t-u 1681 to 2219 539 to 1       539/539
(100 %)
0 diff
(100 %id)
AI952897 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .t-u 1706 to 2221 516 to 1       516/516
(100 %)
0 diff
(100 %id)
AW292681   .t-u 1775 to 2219 462 to 18   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 445/445
(100 %)
8 diff
(98.3 %id)
DB296785 cerebellum .t-u 1953 to 2488 537 to 1       537/537
(100 %)
2 diff
(99.7 %id)
AW474419 serous papillary carcinoma, high grade, 2pooled tumors, uterus .t-u 2029 to 2484 460 to 5   tiling clone,   456/460
(99 %)
0 diff
(100 %id)
BQ002274 Chondrosarcoma, Left Pelvis .t-u 2034 to 2479 465 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 447/447
(100 %)
2 diff
(99.6 %id)
BG056168 brain, glioblastoma with probably TP53 mutation andwithout EGFR amplification .t-u 2040 to 2480 443 to 1       443/443
(100 %)
2 diff
(99.6 %id)
L31942 brain .t-u 2184 to 2480 297 to 1     Submitted on the opposite strand 297/297
(100 %)
4 diff
(98.7 %id)
BF885646 testis_normal .u-u 1 to 505 20 to 520   tiling clone,   501/520
(96 %)
6 diff
(98.9 %id)
BI048481 testis_normal .u-u 1 to 505 20 to 520       501/520
(96 %)
6 diff
(98.9 %id)
AI859624 serous papillary carcinoma, high grade, 2pooled tumors, uterus .u-u 325 to 804 480 to 1 exact tiling clone,   480/480
(100 %)
0 diff
(100 %id)
AW665384 pooled .u-u 328 to 804 476 to 1 exact     476/476
(100 %)
2 diff
(99.6 %id)
AW103666 brain, tumor, 5 pooled (see description) .u-u 398 to 806 409 to 1   tiling clone,   409/409
(100 %)
2 diff
(99.6 %id)
CN291811 embryonic stem cells, DMSO-treated H9 cellline .va-u 1 to 690 1 to 689 exact tiling clone,   689/689
(100 %)
1 diff
(99.9 %id)
BI545571 brain, hippocampus .vb 1 to 587 7 to 596 E59A S62* tiling clone,   590/703
(83 %)
12 diff
(98.3 %id)
TI_44165649   .vb 1 to 587 90 to 679 E59A S62*     590/786
(75 %)
12 diff
(98.5 %id)
DB139019 thymus .vc 1 to 548 2 to 551 exact tiling clone, capped   550/550
(100 %)
2 diff
(99.7 %id)
CD688192 normal nasopharynx .vd-u 1 to 469 46 to 515 L55F Q56T V57G E58G F59I ... tiling clone,   470/515
(91 %)
6 diff
(98.9 %id)
AW080413 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .ve-u 1 to 441 441 to 1 exact tiling clone,   441/441
(100 %)
0 diff
(100 %id)
AL599320   .vf-u 1 to 436 1 to 436 C20W tiling clone,   436/436
(100 %)
3 diff
(99.4 %id)
CB118100 Liver .vg 1 to 127 126 to 1 L12V E38K N39I F40L K42R tiling clone, Submitted on the opposite strand 126/127
(99 %)
2 diff
(98.5 %id)
377 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m-u, .n, .o, .p, .q, .r, .s, .t-u, .u-u, .va-u, .vb, .vc, .vd-u, .ve-u, .vf-u, .vg Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI